Pulmonary Rehabilitation with and without a Cognitive Behavioral Intervention for Breathlessness in People Living with Chronic Obstructive Pulmonary Disease: Randomized Controlled Trial.
Marie T WilliamsHayley LewthwaiteCatherine PaquetPaul A CafarellaPeter FrithPublished in: Journal of clinical medicine (2023)
(1) Background: Most controlled trials of cognitive behavior therapy (CBT) in people living with chronic obstructive pulmonary disease (COPD) have targeted anxiety and depression. (2) Methods: This pragmatic randomized controlled trial explored whether a comprehensive pulmonary rehabilitation program (CPRP) with CBT for breathlessness or social group control (CPRP + SC) significantly improved health outcomes. (3) Results: People with moderate-to-severe COPD were block randomized (CPRP + CBT n = 52 or CPRP + SC n = 49). Primary outcomes (Hospital Anxiety and Depression scale (HADs), six-minute walk distance (6MWD)) and secondary outcomes (breathlessness, quality of life and habitual physical activity) were assessed before and 1, 6 and 12 months post intervention. Between-group differences were calculated with mixed models for each time point to baseline (intention to treat (ITT)). Participants ( n = 101, mean ± SD age 70 ± 8.5 years, 54 (53%) males, FEV 1 % pred 47.7 ± 16.3) were similar between groups. Post intervention, primary outcomes did not differ significantly between groups at 1 (6MWD mean difference -7.5 [95% CI -34.3 to 19.4], HADs-A -0.3 [-1.4 to 0.9], HADs-D 0.2 [-0.8 to 1.3]), 6 (6MWD -11.5 [-38.1 to 15.1], HADs-A 1.1 [0.0 to 2.2], HADs-D 0.2 [-0.9 to 1.3]), or 12 months (6MWD -3.8 [-27.2 to 19.6], HADS-A -0.4 [-1.5 to 0.6], HADs-D -0.7 [-1.7 to 0.4]). (4) Conclusions: In this cohort, combining CBT with a CPRP did not provide additional health benefits beyond those achieved by a standard CPRP.
Keyphrases
- randomized controlled trial
- chronic obstructive pulmonary disease
- study protocol
- lung function
- healthcare
- physical activity
- mental health
- pulmonary hypertension
- public health
- body mass index
- double blind
- metabolic syndrome
- systematic review
- stem cells
- type diabetes
- air pollution
- placebo controlled
- health information
- mesenchymal stem cells
- adverse drug
- high intensity
- drug induced
- social media
- adipose tissue
- glycemic control
- climate change
- acute care
- human health